BRAF alterations are associated with complex mutational profiles in malignant melanoma

作者: Maria Daniotti , Maria Oggionni , Tiziana Ranzani , Viviana Vallacchi , Valentina Campi

DOI: 10.1038/SJ.ONC.1207780

关键词:

摘要: To evaluate the mutational profiles associated with BRAF mutations in human melanoma, we have studied BRAF, RAS, PTEN, TP53, CDKN2A and CDK4 genes their expression melanoma lesions. Owing to lack of sufficient material from fresh specimens, employed short-term cell lines obtained biopsies. In all, 41 eight primary lesions, 20 nodal, 11 cutaneous two visceral metastases patients sporadic (n=31), familial (n=4) multiple (n=2) were analysed. The results revealed novel missense genes. Overall, activating loss functional p16 ARF detected majority melanomas (29/41, 36/41 29/41, respectively), while PTEN alterations/loss, NRAS TP53 occurred less frequently (6/41, 6/41 10/41, respectively). resulting 12 profiles, p16/ARF mutated BRAFV599E was most represented (n=15). addition, always accompanied alterations, found association or absence activation. p16/ARFDelta+BRAF/RAS profile significantly a longer survival, complex highly aggressive disease poor survival. These data support existence several molecularly defined groups which likely reflect different clinical/biological behaviour, thus suggesting that more extensive molecular classification would impact its clinical management.

参考文章(30)
M. Castellano, G. Parmiani, Genes involved in melanoma: an overview of INK4a and other loci. Melanoma Research. ,vol. 9, pp. 421- 432 ,(1999) , 10.1097/00008390-199910000-00001
Jamileh Hashemi, Mikael S. Lindström, Charlotte Asker, Anton Platz, Johan Hansson, Klas G. Wiman, A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF Cancer Letters. ,vol. 180, pp. 211- 221 ,(2002) , 10.1016/S0304-3835(02)00027-7
S F Zerp, A van Elsas, L T C Peltenburg, P I Schrier, p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis British Journal of Cancer. ,vol. 79, pp. 921- 926 ,(1999) , 10.1038/SJ.BJC.6690147
M Deichmann, M Thome, A Benner, U Egner, W Hartschuh, H Näher, PTEN/MMAC1 expression in melanoma resection specimens. British Journal of Cancer. ,vol. 87, pp. 1431- 1436 ,(2002) , 10.1038/SJ.BJC.6600653
Xiao-Ping Zhou, Oliver Gimm, Heather Hampel, Theodore Niemann, Michael J. Walker, Charis Eng, Epigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation American Journal of Pathology. ,vol. 157, pp. 1123- 1128 ,(2000) , 10.1016/S0002-9440(10)64627-5
Lloyd C Trotman, Pier Paolo Pandolfi, PTEN and p53: who will get the upper hand? Cancer Cell. ,vol. 3, pp. 97- 99 ,(2003) , 10.1016/S1535-6108(03)00022-9
Heng Wu, Vikas Goel, Frank G Haluska, PTEN signaling pathways in melanoma Oncogene. ,vol. 22, pp. 3113- 3122 ,(2003) , 10.1038/SJ.ONC.1206451
Nicholas K Hayward, Genetics of melanoma predisposition Oncogene. ,vol. 22, pp. 3053- 3062 ,(2003) , 10.1038/SJ.ONC.1206445